Clinical trial
Valacyclovir in Immunocompromised Children
NCT00059592 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00059592 |
|---|---|
| Title | Valacyclovir in Immunocompromised Children |
| Official title | Valacyclovir in Immunocompromised Children |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Shingles, Bone Marrow Transplantation |
| Intervention type | Drug |
| Interventions | Valacyclovir |
| Enrollment | 37 |
| Start date | Apr 7, 1998 |
| Primary completion | Dec 30, 2004 |
| Completion | May 5, 2005 |
| First posted | Apr 30, 2003 |
| Last update posted | Mar 4, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: